Mahamaya Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 17 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.28 M
- Revenue Growth -3.74%
- Profit Growth -50.82%
- Ebitda -25.97%
- Net Worth 1.40%
- Total Assets -10.96%
About Mahamaya Diagnostic
Mahamaya Diagnostic Private Limited (MDPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2008 and has a history of 17 years. Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹3.28 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santwana Paul, Goutam Pal, and Samrat Pal serve as directors at the Company.
Company Details
- Location
Howrah, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195WB2008PTC122512
- Company No.
122512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Mahamaya Diagnostic?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samrat Pal  | Director | 16-Mar-2024 | Current |
| Santwana Paul | Director | 12-Feb-2008 | Current |
| Goutam Pal | Director | 12-Feb-2008 | Current |
Financial Performance of Mahamaya Diagnostic.
Mahamaya Diagnostic Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.74% decrease. The company also saw a substantial fall in profitability, with a 50.82% decrease in profit. The company's net worth moved up by a moderate rise of 1.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahamaya Diagnostic?
In 2019, Mahamaya Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.28 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2012 | Hdfc Bank Limited | ₹1.25 M | Satisfied |
| 18 Jun 2012 | Hdfc Bank Limited | ₹2.03 M | Satisfied |
How Many Employees Work at Mahamaya Diagnostic?
Mahamaya Diagnostic has a workforce of 6 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahamaya Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahamaya Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.